BG103171A - Azoles containing esters with amino acids as antimycotic forms - Google Patents
Azoles containing esters with amino acids as antimycotic formsInfo
- Publication number
- BG103171A BG103171A BG103171A BG10317199A BG103171A BG 103171 A BG103171 A BG 103171A BG 103171 A BG103171 A BG 103171A BG 10317199 A BG10317199 A BG 10317199A BG 103171 A BG103171 A BG 103171A
- Authority
- BG
- Bulgaria
- Prior art keywords
- antimycotic
- forms
- amino acids
- containing esters
- azoles containing
- Prior art date
Links
- 150000001413 amino acids Chemical class 0.000 title abstract 2
- 230000001857 anti-mycotic effect Effects 0.000 title abstract 2
- 239000002543 antimycotic Substances 0.000 title abstract 2
- 150000003851 azoles Chemical class 0.000 title 1
- 150000002148 esters Chemical class 0.000 title 1
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- WNXJIVFYUVYPPR-UHFFFAOYSA-N 1,3-dioxolane Chemical class C1COCO1 WNXJIVFYUVYPPR-UHFFFAOYSA-N 0.000 abstract 1
- 150000001204 N-oxides Chemical class 0.000 abstract 1
- 125000002252 acyl group Chemical group 0.000 abstract 1
- 235000001014 amino acid Nutrition 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
The invention relates to compounds with the formulawhere -A-B- means bivalent radical with the formula -N=CH- (a),-CH=N - (b), -CH=CH- (c), L meaning acyl residue of aminoacid;D is azole containing 1,3- or 1,4-dioxolan derivative. Theinvention also relates to their N-oxides, pharmaceuticallyacceptable adjunctive salts and stereochemical isomers, to thepreparation of the compounds, to compositions containing them andto their use as wide-spectral antimycotic form.19 claims
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP97200374 | 1997-02-11 | ||
| EP97203228 | 1997-10-15 | ||
| PCT/EP1998/000646 WO1998034934A1 (en) | 1997-02-11 | 1998-02-03 | Amino acid ester containing azole antifungals |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BG103171A true BG103171A (en) | 1999-09-30 |
| BG63872B1 BG63872B1 (en) | 2003-04-30 |
Family
ID=26146124
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BG103171A BG63872B1 (en) | 1997-02-11 | 1999-02-11 | Azoles containing esters with amino acids as antimycotic forms |
Country Status (31)
| Country | Link |
|---|---|
| US (3) | US6262052B1 (en) |
| EP (1) | EP0958289B1 (en) |
| JP (1) | JP4347911B2 (en) |
| KR (1) | KR100509171B1 (en) |
| CN (1) | CN1238353C (en) |
| AT (1) | ATE270290T1 (en) |
| AU (1) | AU725302C (en) |
| BG (1) | BG63872B1 (en) |
| BR (1) | BR9809744A (en) |
| CA (1) | CA2262791C (en) |
| CZ (1) | CZ297197B6 (en) |
| DE (1) | DE69824834T2 (en) |
| DK (1) | DK0958289T3 (en) |
| EE (1) | EE03876B1 (en) |
| ES (1) | ES2224364T3 (en) |
| HU (1) | HU227744B1 (en) |
| ID (1) | ID21755A (en) |
| IL (2) | IL128513A (en) |
| MY (1) | MY129537A (en) |
| NO (1) | NO316668B1 (en) |
| NZ (1) | NZ334477A (en) |
| PL (1) | PL191152B1 (en) |
| PT (1) | PT958289E (en) |
| RU (1) | RU2197489C2 (en) |
| SI (1) | SI0958289T1 (en) |
| SK (1) | SK284910B6 (en) |
| TR (1) | TR199900584T2 (en) |
| TW (1) | TW495508B (en) |
| UA (1) | UA61919C2 (en) |
| WO (1) | WO1998034934A1 (en) |
| ZA (1) | ZA981079B (en) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0957101A1 (en) * | 1998-05-14 | 1999-11-17 | Janssen Pharmaceutica N.V. | Water soluble azoles as broad-spectrum antifungals |
| AU1915500A (en) | 1998-11-20 | 2000-06-13 | Bristol-Myers Squibb Company | Water soluble prodrugs of azole compounds |
| AU768491B2 (en) * | 1999-05-04 | 2003-12-11 | Janssen Pharmaceutica N.V. | Antifungal ethers |
| AU2002365077A1 (en) * | 2001-09-19 | 2003-06-30 | Massachusetts Institute Of Technology | Methods and products related to non-viral transfection |
| ITMI20032020A1 (en) | 2003-10-17 | 2005-04-18 | Italfarmaco Spa | NEW AZOLIC ANTIFUNGAL AGENTS WITH DIFFERENT INTERACTION WITH METABOLIC CYTOCOMMAS |
| CN102906087B (en) * | 2010-05-19 | 2016-03-23 | 桑多斯股份公司 | Prepare the method for chiral triazole ketone |
| JP6687625B2 (en) | 2014-12-30 | 2020-04-22 | ダウ アグロサイエンシィズ エルエルシー | Picolinamide compound having fungicidal activity |
| BR102019004480B1 (en) * | 2018-03-08 | 2023-03-28 | Dow Agrosciences Llc | PICOLINAMIDES AS FUNGICIDES |
| CN111138421A (en) * | 2019-12-26 | 2020-05-12 | 上海英诺富成生物科技有限公司 | Antifungal water-soluble compound and preparation method and application thereof |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4267179A (en) | 1978-06-23 | 1981-05-12 | Janssen Pharmaceutica, N.V. | Heterocyclic derivatives of (4-phenylpiperazin-1-yl-aryloxymethyl-1,3-dioxolan-2-yl)methyl-1H-imidazoles and 1H-1,2,4-triazoles |
| US4791111A (en) * | 1985-12-23 | 1988-12-13 | Janssen Pharmaceutica, N.V. | [[4-[4-(4-phenyl-1-piperazinyl)phenoxymethyl]-1,3-dioxolan-2-yl]methyl]-1H-imidazoles and 1H-1,2,4-triazoles having anti-microbial properties |
| US4916134A (en) | 1987-03-25 | 1990-04-10 | Janssen Pharmacuetica N.V. | 4-[4-[4-[4-[[2-(2,4-difluorophenyl)-2-(1H-azolylmethyl)-1,3-dioxolan-4-yl]me]phenyl]-1-piperazinyl]phenyl]triazolones |
| CA1331757C (en) | 1988-02-29 | 1994-08-30 | Janssen Pharmaceutica Naamloze Vennootschap | 5-lipoxygenase inhibiting 4-(4-phenyl-1-piperazinyl)phenols |
| NZ233502A (en) * | 1989-06-09 | 1991-11-26 | Janssen Pharmaceutica Nv | 4-(1,2,4-triazole- or imidazole-phenyl-substituted) -1-(1,3-dioxolan-4-ylmethoxyphenyl) piperazine derivatives; preparatory processes: fungicidal and antiviral compositions |
| CA2117651C (en) | 1992-03-18 | 2006-01-03 | Jan Heeres | Itraconazole and saperconazole stereoisomers |
| PL181193B1 (en) * | 1993-12-21 | 2001-06-29 | Schering Corp | Tetrahydrofuranic antimycotic agents |
| SG48386A1 (en) * | 1994-01-24 | 1998-04-17 | Janssen Pharmaceutica Nv | Watersoluble azole antifungals |
| HUP9701690A3 (en) | 1995-06-02 | 1998-04-28 | Schering Corp Kenilwort | Tetrahydrofuran derivatives as antifungals and pharmaceutical compositions containing the same |
| IL118668A0 (en) * | 1995-06-19 | 1996-10-16 | Schering Corp | Tetrahydrofuran antifungals |
-
1998
- 1998-02-03 WO PCT/EP1998/000646 patent/WO1998034934A1/en not_active Ceased
- 1998-02-03 PT PT98908064T patent/PT958289E/en unknown
- 1998-02-03 EP EP98908064A patent/EP0958289B1/en not_active Expired - Lifetime
- 1998-02-03 PL PL332008A patent/PL191152B1/en unknown
- 1998-02-03 RU RU99106585/04A patent/RU2197489C2/en active
- 1998-02-03 KR KR10-1999-7001983A patent/KR100509171B1/en not_active Expired - Lifetime
- 1998-02-03 AT AT98908064T patent/ATE270290T1/en active
- 1998-02-03 ES ES98908064T patent/ES2224364T3/en not_active Expired - Lifetime
- 1998-02-03 DK DK98908064T patent/DK0958289T3/en active
- 1998-02-03 HU HU0001050A patent/HU227744B1/en unknown
- 1998-02-03 SI SI9830687T patent/SI0958289T1/en unknown
- 1998-02-03 JP JP53376398A patent/JP4347911B2/en not_active Expired - Lifetime
- 1998-02-03 CA CA002262791A patent/CA2262791C/en not_active Expired - Lifetime
- 1998-02-03 IL IL12851398A patent/IL128513A/en not_active IP Right Cessation
- 1998-02-03 CZ CZ0283599A patent/CZ297197B6/en not_active IP Right Cessation
- 1998-02-03 AU AU66207/98A patent/AU725302C/en not_active Expired
- 1998-02-03 SK SK1059-99A patent/SK284910B6/en not_active IP Right Cessation
- 1998-02-03 TR TR1999/00584T patent/TR199900584T2/en unknown
- 1998-02-03 NZ NZ334477A patent/NZ334477A/en not_active IP Right Cessation
- 1998-02-03 US US09/355,369 patent/US6262052B1/en not_active Expired - Lifetime
- 1998-02-03 ID IDW990505A patent/ID21755A/en unknown
- 1998-02-03 DE DE69824834T patent/DE69824834T2/en not_active Expired - Lifetime
- 1998-02-03 BR BR9809744-0A patent/BR9809744A/en not_active Application Discontinuation
- 1998-02-03 CN CNB988011352A patent/CN1238353C/en not_active Expired - Lifetime
- 1998-02-03 EE EEP199900100A patent/EE03876B1/en unknown
- 1998-02-09 TW TW087101662A patent/TW495508B/en not_active IP Right Cessation
- 1998-02-09 MY MYPI98000513A patent/MY129537A/en unknown
- 1998-02-10 ZA ZA9801079A patent/ZA981079B/en unknown
- 1998-03-02 UA UA99020835A patent/UA61919C2/en unknown
-
1999
- 1999-02-02 NO NO19990484A patent/NO316668B1/en not_active IP Right Cessation
- 1999-02-11 BG BG103171A patent/BG63872B1/en unknown
-
2001
- 2001-05-04 US US09/848,989 patent/US6512116B2/en not_active Expired - Lifetime
-
2002
- 2002-04-23 IL IL149285A patent/IL149285A/en not_active IP Right Cessation
- 2002-11-15 US US10/298,038 patent/US6703506B2/en not_active Expired - Lifetime
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL133623A0 (en) | Antithrombotic agents | |
| IL133627A0 (en) | Antithrombotic agents | |
| LU91145I2 (en) | FIROCOXIB optionally in the form of a pharmaceutically acceptable salt (PREVICOX). | |
| BG106013A (en) | New compounds and compositions as protease inhibitors | |
| GR3032220T3 (en) | Use of 2-(N-(2-aminoethyl)amino)acetic acid derivatives for the treatment of diseases which are mediated by non-enzymatical glycosylation | |
| YU52000A (en) | Meta-azacyclic amino benzoic acid compounds and derivatives thereof being integrin antagonists | |
| BG103171A (en) | Azoles containing esters with amino acids as antimycotic forms | |
| WO2001072263A3 (en) | Use of ectoin or ectoin derivatives for protecting stress proteins in the skin | |
| EA199801028A1 (en) | APPLICATION OF DERIVATIVES OF P-AMINOPHENOL FOR PREPARATION OF PHARMACEUTICAL COMPOSITIONS USED IN THE TREATMENT OF NEURODEGENERATIVE DISEASES | |
| EP1019047A4 (en) | Antithrombotic agents | |
| DE3568424D1 (en) | Acetylenic phenoxypropanol derivatives and pharmaceutical compositions for the treatment of hypertension | |
| ATE116974T1 (en) | 5- PIPERAZINYLALKYL-1,5-BENZOTHIAZEPINONE USED AS CALCIUM ANTAGONISTS. | |
| EP1027051A4 (en) | Antithrombotic agents | |
| EP0802179A4 (en) | SUBSTITUTED AMIDINONAPHTYLE ESTER DERIVATIVES | |
| ZA94183B (en) | Ketorolac derivatives with considerably reduced gastro-intestinal irritation and ulceration | |
| EP0980366A4 (en) | Antithrombotic agents | |
| AR004401A1 (en) | THYROSINE DERIVATIVES, PROCEDURE TO PREPARE THEM AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM. | |
| MX9702532A (en) | Pharmaceutical compositions for the treatment of rhinitis. |